Matthew Sinnreich - Jul 21, 2022 Form 3 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role: COO and Acting CEO
Signature: /s/ Matthew Sinnreich
Stock symbol: OCEL
Transactions as of: Jul 21, 2022
Transactions value $: $0
Form type: 3
Date filed: 7/26/2022, 04:05 PM
Next filing: Oct 17, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	OCEL	Common Stock, $0.001 par value						10M	Jul 21, 2022	Direct	F1
holding	OCEL	Common Stock, $0.001 par value						24M	Jul 21, 2022	Direct	F2
holding	OCEL	Common Stock, $0.001 par value						7M	Jul 21, 2022	See Footnote	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	OCEL	Warrants to Purchase Common Stock							Jul 21, 2022	Common Stock, par value $0.001 per share	40M	$0.03	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock and warrants to purchase common stock issued to the Reporting Person as a signing bonus in connection with his employment as the Issuer's Chief Operating Officer and Acting Chief Executive Officer.
F2	Represents shares of common stock issued to the Reporting Person as compensation during for his first year of employment. The shares vest in twelve monthly installments of 2,000,000 shares each, subject to continued employment.
F3	Represents shares of common stock held by Retrograde Investments, LLC, in which entity the Reporting Person is a minority holder and over which the Reporting Person has shared voting and dispositive power.